Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules
- Department of Oncology, Division of Clinical Sciences, St. George's, University of London, London, U.K.
- Correspondence to: Wai Liu, Ph.D., Dept of Oncology, Division of Clinical Sciences, St. George's, University of London, 2nd Floor, Jenner Wing, London, SW17 0RE, U.K. Tel: +44 02087255037, e-mail: w.liu{at}sgul.ac.uk
Abstract
Cannabinoids are the bioactive components of the Cannabis plant that display a diverse range of therapeutic qualities. We explored the activity of six cannabinoids, used both alone and in combination in leukaemic cells. Cannabinoids were cytostatic and caused a simultaneous arrest at all phases of the cell cycle. Re-culturing pre-treated cells in drug-free medium resulted in dramatic reductions in cell viability. Furthermore, combining cannabinoids was not antagonistic. We suggest that the activities of some cannabinoids are influenced by treatment schedules; therefore, it is important to carefully select the most appropriate strategy in order to maximise their efficacy.
Footnotes
-
Conflicts of Interest
KAS, SS and AGD have no conflict of interests. WML is in receipt of research funding from GW Pharmaceuticals Ltd.
- Received July 16, 2013.
- Revision received August 6, 2013.
- Accepted August 8, 2013.
- Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved







